A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination.

Journal: Dermatology Online Journal
Published:
Abstract

The rapid development and implementation of COVID-19 vaccines throughout the global population has given rise to unique, rare, adverse skin reactions. This case report describes an elderly man with new-onset bullous pemphigoid following the second dose of the Pfizer-BioNTech (mRNA) COVID-19 vaccine.

Authors
Bryan Daines, Lauren Madigan, Patricia Vitale, Mazdak Khalighi, Matthew Innes